FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

L B A Van De Putte

Research Profile

Disorders

Chemicals & Drugs

Living Beings

Procedures

Double-Blind Method

Anatomy

Concepts & Ideas

Co-author Network

Publications

TOP 3
M Zandbelt; L te Boome; Ina S Klasen; L B A Van De Putte; F H J van den Hoogen
Tear fluid measurement of anti-SS-A and anti-SS-B antibody in anti-SS-A and anti-SS-B seronegative Sjögren's syndrome patients.
Laëtitia Michou; Sandra Lasbleiz; Anne-Christine Rat; Paola Migliorini; Alejandro Balsa; René Westhovens; Pilar Barrera; Helena Alves; Céline Pierlot; Elodie Glikmans; Sophie Garnier; Jean Dausset; Carlos Vaz; Manuela Fernandes; Elisabeth Petit-Teixeira; Isabelle Lemaire; Dora Pascual-Salcedo; Stefano Bombardieri; Jan Dequeker; Timothy Radstake; Piet Van Riel; L B A Van De Putte; Antonio Lopes-Vaz; Bernard Prum; Thomas Bardin; Philippe Dieudé; François Cornélis
Linkage proof for PTPN22, a rheumatoid arthritis susceptibility gene and a human autoimmunity gene.
Michiel M Zandbelt; Jos G A Houbiers; F H J van den Hoogen; Jan Meijerink; P L C M van Riel; Joanneke in't Hout; L B A Van De Putte
Intranasal administration of recombinant human cartilage glycoprotein-39. A phase I escalating cohort study in patients with rheumatoid arthritis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of L B A Van De Putte (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2009: M Zandbelt; L te Boome; Ina S Klasen; L B A Van De Putte; F H J van den Hoogen
Tear fluid measurement of anti-SS-A and anti-SS-B antibody in anti-SS-A and anti-SS-B seronegative Sjögren's syndrome patients.
Clinical and experimental rheumatology 2009;27(3):536.
2007: Laëtitia Michou; Sandra Lasbleiz; Anne-Christine Rat; Paola Migliorini; Alejandro Balsa; René Westhovens; Pilar Barrera; Helena Alves; Céline Pierlot; Elodie Glikmans; Sophie Garnier; Jean Dausset; Carlos Vaz; Manuela Fernandes; Elisabeth Petit-Teixeira; Isabelle Lemaire; Dora Pascual-Salcedo; Stefano Bombardieri; Jan Dequeker; Timothy Radstake; Piet Van Riel; L B A Van De Putte; Antonio Lopes-Vaz; Bernard Prum; Thomas Bardin; Philippe Dieudé; François Cornélis
Linkage proof for PTPN22, a rheumatoid arthritis susceptibility gene and a human autoimmunity gene.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(5):1649-54.
2006: Michiel M Zandbelt; Jos G A Houbiers; F H J van den Hoogen; Jan Meijerink; P L C M van Riel; Joanneke in't Hout; L B A Van De Putte
Intranasal administration of recombinant human cartilage glycoprotein-39. A phase I escalating cohort study in patients with rheumatoid arthritis.
The Journal of rheumatology 2006;33(9):1726-33.
2006: T K Kvien; L B A Van De Putte
EULAR expects further development in 2006.
Annals of the rheumatic diseases 2006;65(1):1.
2005: Walther J van Venrooij; L B A Van De Putte
Is assaying autoantibodies useful for diagnosing early rheumatoid arthritis?
Nature clinical practice. Rheumatology 2005;1(1):4-5.
2005: A M M Eijsbouts; F H J van den Hoogen; R F J M Laan; Ad R M M Hermus; C G J Sweep; L B A Van De Putte
Hypothalamic-pituitary-adrenal axis activity in patients with rheumatoid arthritis.
Clinical and experimental rheumatology 2005;23(5):658-64.
2005: A M M Eijsbouts; F H J van den Hoogen; R F J M Laan; C G J Sweep; Ad R M M Hermus; L B A Van De Putte
Decreased prolactin response to hypoglycaemia in patients with rheumatoid arthritis: correlation with disease activity.
Annals of the rheumatic diseases 2005;64(3):433-7.
2005: JIMMY MOLYNEUX; Eric Abadie; Bernard Avouac; Gilles Bouvenot; Jaime Branco; Olivier Bruyere; Gonzalo Calvo; Jean-Pierre Devogelaer; Renèe-Liliane Dreiser; Gabriel Herrero-Beaumont; A Kahan; Gottfried Kreutz; Andrea Laslop; Ernst-Martin Lemmel; C J Menkes; Karel Pavelka; L B A Van De Putte; Luc VanHaelst; Jean-Yves Reginster
Total joint replacement of hip or knee as an outcome measure for structure modifying trials in osteoarthritis.
Osteoarthritis and cartilage / OARS, Osteoarthritis Research Society 2005;13(1):13-9.
2005: M C W Creemers; M J A M Franssen; M A van't Hof; F W J Gribnau; L B A Van De Putte; P L C M van Riel
Assessment of outcome in ankylosing spondylitis: an extended radiographic scoring system.
Annals of the rheumatic diseases 2005;64(1):127-9.
2004: Margriet Hartman; Annelies van Ede; Johan L Severens; R F J M Laan; L B A Van De Putte; Gert Jan van der Wilt
Economic evaluation of folate supplementation during methotrexate treatment in rheumatoid arthritis.
The Journal of rheumatology 2004;31(5):902-8.
2004: L B A Van De Putte; C Atkins; Michel Malaise; Jacques Sany; A S Russell; P L C M van Riel; Lucas Settas; J W J Bijlsma; S Todesco; Maxime Dougados; P Nash; P Emery; N Walter; M Kaul; Steven Fischkoff; Hartmut Kupper
Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous disease modifying antirheumatic drug treatment has failed.
Annals of the rheumatic diseases 2004;63(5):508-16.
2004: Eric Abadie; Dominique Ethgen; Bernard Avouac; Gilles Bouvenot; Jaime Branco; Olivier Bruyere; Gonzalo Calvo; Jean-Pierre Devogelaer; Renèe-Liliane Dreiser; Gabriel Herrero-Beaumont; Andre Kahan; Gottfried Kreutz; Andrea Laslop; Ernst-Martin Lemmel; George Nuki; L B A Van De Putte; Luc VanHaelst; Jean-Yves Reginster
Recommendations for the use of new methods to assess the efficacy of disease-modifying drugs in the treatment of osteoarthritis.
Osteoarthritis and cartilage / OARS, Osteoarthritis Research Society 2004;12(4):263-8.
2004: Rolf Rau; S Simianer; P L C M van Riel; L B A Van De Putte; K Krüger; Manfred Schattenkirchner; C F Allaart; F C Breedveld; Joachim Kempeni; K Beck; Hartmut Kupper
Rapid alleviation of signs and symptoms of rheumatoid arthritis with intravenous or subcutaneous administration of adalimumab in combination with methotrexate.
Scandinavian journal of rheumatology 2004;33(3):145-53.
2004: Michiel M Zandbelt; Peter C M de Wilde; Philip van Damme; Carel B Hoyng; L B A Van De Putte; Frank van den Hoogen
Etanercept in the treatment of patients with primary Sjögren's syndrome: a pilot study.
The Journal of rheumatology 2004;31(1):96-101.
2003: L B A Van De Putte; Rolf Rau; F C Breedveld; Joachim R Kalden; Michel Malaise; P L C M van Riel; Manfred Schattenkirchner; P Emery; Gerd R Burmester; H Zeidler; H M Moutsopoulos; K Beck; Hartmut Kupper
Efficacy and safety of the fully human anti-tumour necrosis factor alpha monoclonal antibody adalimumab (D2E7) in DMARD refractory patients with rheumatoid arthritis: a 12 week, phase II study.
Annals of the rheumatic diseases 2003;62(12):1168-77.
2003: Daniel E Furst; Ferdinand C Breedveld; JR Kalden; JS Smolen; Gerd R Burmester; M Dougados; P Emery; Allan Gibofsky; Arthur F Kavanaugh; Edward C Keystone; LG Klareskog; A S Russell; L B A Van De Putte; Michael H Weisman; A F Kavenaugh
Updated consensus statement on biological agents for the treatment of rheumatoid arthritis and other immune mediated inflammatory diseases (May 2003).
Annals of the rheumatic diseases 2003;62 Suppl 2():ii2-9.
2003: Niek de Vries; Paul P Tak; Henk Tijssen; P L C M van Riel; L B A Van De Putte
Female sex increases risk for rheumatoid arthritis only in individuals encoding low-risk HLA-DRB1 alleles.
Arthritis and rheumatism 2003;48(6):1762-3.
2003: Timothy Radstake; Elisabeth Petit; Cieline Pierlot; L B A Van De Putte; François Cornelis; Pilar Barrera
Role of Fcgamma receptors IIA, IIIA, and IIIB in susceptibility to rheumatoid arthritis.
The Journal of rheumatology 2003;30(5):926-33.
2003: Rolf Rau; Oliver Sander; P L C M van Riel; L B A Van De Putte; Fritz Hasler; Michel Zaug; Johannes Kneer; Philippe van der Auwera; Randall M Stevens
Intravenous human recombinant tumor necrosis factor receptor p55-Fc IgG1 fusion protein Ro 45-2081 (lenercept): a double blind, placebo controlled dose-finding study in rheumatoid arthritis.
The Journal of rheumatology 2003;30(4):680-90.
2003: Walther J van Venrooij; L B A Van De Putte; Frank H J van den Hoogen
Anti-cyclic citrullinated peptide antibody in early rheumatoid arthritis: comment on the editorial by Scott.
Arthritis and rheumatism 2003;48(3):857; author reply 857-8.
2003: W J van Venrooij; L B A Van De Putte
[Early diagnosis of rheumatoid arthritis with a test based upon a specific antigen: cyclic citrullinated peptide].
Nederlands tijdschrift voor geneeskunde 2003;147(5):191-4.
2003: Gerald J D Hengstman; F H J van den Hoogen; Pilar Barrera; M G Netea; Allan J Pieterse; L B A Van De Putte; B G M van Engelen
Successful treatment of dermatomyositis and polymyositis with anti-tumor-necrosis-factor-alpha: preliminary observations.
European neurology 2003;50(1):10-5.
2002: Annelies van Ede; R F J M Laan; R A De Abreu; A B J Stegeman; L B A Van De Putte
Purine enzymes in patients with rheumatoid arthritis treated with methotrexate.
Annals of the rheumatic diseases 2002;61(12):1060-4.
2002: L B A Van De Putte
Key randomized trials of single agents in early rheumatoid arthritis.
The Journal of rheumatology. Supplement 2002;66():13-9.
2002: Alfons A den Broeder; L B A Van De Putte; Rolf Rau; Manfred Schattenkirchner; P L C M van Riel; Oliver Sander; Christina Binder; Helmut Fenner; Yvonne Bankmann; Raja Velagapudi; Joachim Kempeni; Hartmut Kupper
A single dose, placebo controlled study of the fully human anti-tumor necrosis factor-alpha antibody adalimumab (D2E7) in patients with rheumatoid arthritis.
The Journal of rheumatology 2002;29(11):2288-98.
2002: Lee S Simon; Josef S Smolen; Steven B Abramson; Gerald Appel; Claire Bombardier; D Craig Brater; Ferdinand C Breedveld; K Brune; Gerd R Burmester; Leslie J Crofford; Maxime Dougados; Raymond DuBois; garret fitzgerald; W Frishman; Luis A García Rodríguez; Marc C Hochberg; Joachim R Kalden; Loren Laine; M J S Langman; Stephen M Prescott; L B A Van De Putte; Andrew Whelton; William B White; Gordon H Willaims
Controversies in COX-2 selective inhibition.
The Journal of rheumatology 2002;29(7):1501-10.
2002: Michiel M Zandbelt; J R M Wentink; Peter C M de Wilde; P A van Damme; L B A Van De Putte; F H J van den Hoogen
The synergistic value of focus score and IgA% score of sublabial salivary gland biopsy for the accuracy of the diagnosis of Sjögren's syndrome: a 10-year comparison.
Rheumatology (Oxford, England) 2002;41(7):819-23.
2002: Annelies van Ede; R F J M Laan; Henk J Blom; G H J Boers; Cees Haagsma; C M G Thomas; Theo M de Boo; L B A Van De Putte
Homocysteine and folate status in methotrexate-treated patients with rheumatoid arthritis.
Rheumatology (Oxford, England) 2002;41(6):658-65.
2002: Annelies Boonen; L B A Van De Putte
Colchicum autumnale from Het Cruydtboeck by Rembertus Dodonaeus.
Annals of the rheumatic diseases 2002;61(6):492.
2002: Niek de Vries; P L C M van Riel; L B A Van De Putte
Research in complex diseases.
Lancet 2002;359(9313):1243-5.
2002: Pilar Barrera; A van der Maas; Annelies van Ede; B A L M Kiemeney; R F J M Laan; L B A Van De Putte; P L C M van Riel
Drug survival, efficacy and toxicity of monotherapy with a fully human anti-tumour necrosis factor-alpha antibody compared with methotrexate in long-standing rheumatoid arthritis.
Rheumatology (Oxford, England) 2002;41(4):430-9.
2002: Niek de Vries; Henk Tijssen; P L C M van Riel; L B A Van De Putte
Reshaping the shared epitope hypothesis: HLA-associated risk for rheumatoid arthritis is encoded by amino acid substitutions at positions 67-74 of the HLA-DRB1 molecule.
Arthritis and rheumatism 2002;46(4):921-8.
2002: Alfons A den Broeder; Leo A B Joosten; T Saxne; D Heinegård; Helmut Fenner; André M M Miltenburg; W L H Frasa; Lambertus J H Van Tits; W A Buurman; P L C M van Riel; L B A Van De Putte; Pilar Barrera
Long term anti-tumour necrosis factor alpha monotherapy in rheumatoid arthritis: effect on radiological course and prognostic value of markers of cartilage turnover and endothelial activation.
Annals of the rheumatic diseases 2002;61(4):311-8.
2001: P L E M van Lent; K C A M Nabbe; Arjen B Blom; A E M Holthuysen; Annet Sloetjes; L B A Van De Putte; Sjef Verbeek; Wim B van den Berg
Role of activatory Fc gamma RI and Fc gamma RIII and inhibitory Fc gamma RII in inflammation and cartilage destruction during experimental antigen-induced arthritis.
The American journal of pathology 2001;159(6):2309-20.
2001: Pilar Barrera; S Fauré; JF Prud'homme; Alejandro Balsa; Paola Migliorini; Daniele Chimenti; Timothy Radstake; L B A Van De Putte; Dora Pascual-Salcedo; René Westhovens; K Maenaut; Helena Alves; Antonio Lopes-Vaz; C Stravopoulos; Marilyn Spyropoulou; P Fritz; Thomas Bardin; Dominique Charron; Virginia Lepage; Maria Martinez; François Cornélis
European genetic study on rheumatoid arthritis: is there a linkage of the interleukin-1 (IL-1), IL-10 or IL-4 genes to RA?
Clinical and experimental rheumatology 2001;19(6):709-14.
2001: Annelies van Ede; R F J M Laan; Henk J Blom; Tom W J Huizinga; Cees Haagsma; Belinda A J Giesendorf; Theo M de Boo; L B A Van De Putte
The C677T mutation in the methylenetetrahydrofolate reductase gene: a genetic risk factor for methotrexate-related elevation of liver enzymes in rheumatoid arthritis patients.
Arthritis and rheumatism 2001;44(11):2525-30.
2001: H A van Heereveld; R F J M Laan; F H J van den Hoogen; M C Malefijt; I R Novakova; L B A Van De Putte
Prevention of symptomatic thrombosis with short term (low molecular weight) heparin in patients with rheumatoid arthritis after hip or knee replacement.
Annals of the rheumatic diseases 2001;60(10):974-6.
2001: E J A Kroot; Anke M van Gestel; Hilde L Swinkels; M M Albers; L B A Van De Putte; P L C M van Riel
Chronic comorbidity in patients with early rheumatoid arthritis: a descriptive study.
The Journal of rheumatology 2001;28(7):1511-7.
2001: Annelies van Ede; R F J M Laan; M J Rood; Tom W J Huizinga; M A F J van de Laar; C J van Denderen; T A Westgeest; T C Romme; D J de Rooij; M J Jacobs; Theo M de Boo; Gert Jan van der Wilt; Johan L Severens; Margriet Hartman; Paul Krabbe; B A Dijkmans; F C Breedveld; L B A Van De Putte
Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis: a forty-eight week, multicenter, randomized, double-blind, placebo-controlled study.
Arthritis and rheumatism 2001;44(7):1515-24.
2001: Pilar Barrera; Leo A B Joosten; Alfons A den Broeder; L B A Van De Putte; P L C M van Riel; Wim B van den Berg
Effects of treatment with a fully human anti-tumour necrosis factor alpha monoclonal antibody on the local and systemic homeostasis of interleukin 1 and TNFalpha in patients with rheumatoid arthritis.
Annals of the rheumatic diseases 2001;60(7):660-9.
2001: Pilar Barrera; Alejandro Balsa; Helena Alves; René Westhovens; K Maenaut; François Cornélis; P Fritz; Thomas Bardin; M Ceu Maia; Antonio Lopes-Vaz; Dora Pascual-Salcedo; Emilio G De-la-Concha; Timothy Radstake; L B A Van De Putte; Paola Migliorini; J F Prudhomme; Dominique Charron; Marilyn Spyropoulou; A Mendes; M Spaepen; Maria Martinez; C Stavropoulos
Noninherited maternal antigens do not increase the susceptibility for familial rheumatoid arthritis. European Consortium on Rheumatoid Arthritis Families (ECRAF).
The Journal of rheumatology 2001;28(5):968-74.
2001: Timothy Radstake; Pilar Barrera; M J Albers; Hilde L Swinkels; L B A Van De Putte; P L C M van Riel
Genetic anticipation in rheumatoid arthritis in Europe. European Consortium on Rheumatoid Arthritis Families.
The Journal of rheumatology 2001;28(5):962-7.
2001: Alfons A den Broeder; F H J van den Hoogen; L B A Van De Putte
Isolated digital vasculitis in a patient with rheumatoid arthritis: good response to tumour necrosis factor alpha blocking treatment.
Annals of the rheumatic diseases 2001;60(5):538-9.
2001: Michiel M Zandbelt; F H J van den Hoogen; Peter C M de Wilde; P J van den Berg; H G Schneider; L B A Van De Putte
Reversibility of histological and immunohistological abnormalities in sublabial salivary gland biopsy specimens following treatment with corticosteroids in Sjögren's syndrome.
Annals of the rheumatic diseases 2001;60(5):511-3.
2000: E J A Kroot; Miek A van Leeuwen; Martin H van Rijswijk; ML Prevoo; M A Van 't Hof; L B A Van De Putte; P L C M van Riel
No increased mortality in patients with rheumatoid arthritis: up to 10 years of follow up from disease onset.
Annals of the rheumatic diseases 2000;59(12):954-8.
2000: Daniel E Furst; Ferdinand C Breedveld; Gerd R Burmester; J J Crofford; P Emery; M Feldmann; JR Kalden; Arthur F Kavanaugh; Edward C Keystone; LG Klareskog; PE Lipsky; RN Maini; A S Russell; David Scott; JS Smolen; L B A Van De Putte; T L Visher; Michael H Weisman
Updated consensus statement on tumour necrosis factor blocking agents for the treatment of rheumatoid arthritis (May 2000).
Annals of the rheumatic diseases 2000;59 Suppl 1():i1-2.
2000: Pilar Barrera; A Blom; P L E M van Lent; L van Bloois; J H Beijnen; N van Rooijen; Maarten C de Waal Malefijt; L B A Van De Putte; G Storm; Wim B van den Berg
Synovial macrophage depletion with clodronate-containing liposomes in rheumatoid arthritis.
Arthritis and rheumatism 2000;43(9):1951-9.
2000: R J Rodenburg; A Ganga; P L van Lent; L B A Van De Putte; Walther J van Venrooij
The antiinflammatory drug sulfasalazine inhibits tumor necrosis factor alpha expression in macrophages by inducing apoptosis.
Arthritis and rheumatism 2000;43(9):1941-50.
2000: E J A Kroot; Brigit A de Jong; Miek A van Leeuwen; Hilde L Swinkels; F H J van den Hoogen; M van't Hof; L B A Van De Putte; Martin H van Rijswijk; Walther J van Venrooij; P L C M van Riel
The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis.
Arthritis and rheumatism 2000;43(8):1831-5.
2000: P J Kerstens; AM Boerbooms; M E Jeurissen; R de Graaf; J Mulder; L B A Van De Putte
Radiological and clinical results of longterm treatment of rheumatoid arthritis with methotrexate and azathioprine.
The Journal of rheumatology 2000;27(5):1148-55.
2000: Pilar Barrera; Alejandro Balsa; Helena Alves; René Westhovens; K Maenaut; François Cornélis; P Fritz; Thomas Bardin; G de Almeida; Antonio Lopes-Vaz; Dora Pascual-Salcedo; Emilio G De-la-Concha; Timothy Radstake; L B A Van De Putte; Paola Migliorini; JF Prud'homme; Dominique Charron; Marilyn Spyropoulou; A Mendes; M Spaepen; Maria Martinez; Virginia Lepage; C Stravopoulos
Noninherited maternal antigens do not play a role in rheumatoid arthritis susceptibility in Europe. European Consortium on Rheumatoid Arthritis Families.
Arthritis and rheumatism 2000;43(4):758-64.
2000: P L E M van Lent; A J van Vuuren; Arjen B Blom; A E M Holthuysen; L B A Van De Putte; J G van de Winkel; Wim B van den Berg
Role of Fc receptor gamma chain in inflammation and cartilage damage during experimental antigen-induced arthritis.
Arthritis and rheumatism 2000;43(4):740-52.
2000: Timothy Radstake; Pilar Barrera; JM Albers; Hilde L Swinkels; L B A Van De Putte; P L C M van Riel
Familial vs sporadic rheumatoid arthritis (RA). A prospective study in an early RA inception cohort.
Rheumatology (Oxford, England) 2000;39(3):267-73.
2000: Désirée van der Heijde; P L van Riel; I H Nuver-Zwart; L B A Van De Putte
Alternative methods for analysis of radiographic damage in a randomized, double blind, parallel group clinical trial comparing hydroxychloroquine and sulfasalazine.
The Journal of rheumatology 2000;27(2):535-8; discussion 538-9.
2000: Arjen B Blom; P L E M van Lent; H van Vuuren ; A E M Holthuysen; C Jacobs; L B A Van De Putte; J G van de Winkel ; Wim B van den Berg
Fc gamma R expression on macrophages is related to severity and chronicity of synovial inflammation and cartilage destruction during experimental immune-complex-mediated arthritis (ICA).
Arthritis research 2000;2(6):489-503.
1999: E J A Kroot; L B A Van De Putte; P L C M van Riel
Management of therapy-resistant rheumatoid arthritis.
Baillière's best practice & research. Clinical rheumatology 1999;13(4):737-52.
1999: L B A Van De Putte; E J A Kroot; P L C M van Riel
Management of refractory rheumatoid arthritis.
Rheumatology (Oxford, England) 1999;38 Suppl 2():32-4.
1999: A M M Eijsbouts; Frank van den Hoogen; R F J M Laan; R M Hermus; F C Sweep; L B A Van De Putte
Treatment of rheumatoid arthritis with the dopamine agonist quinagolide.
The Journal of rheumatology 1999;26(10):2284-5.
1999: RJ Rodenburg; F H J van den Hoogen; Pilar Barrera; Walther J van Venrooij; L B A Van De Putte
Superinduction of interleukin 8 mRNA in activated monocyte derived macrophages from rheumatoid arthritis patients.
Annals of the rheumatic diseases 1999;58(10):648-52.
1999: Niek de Vries; C van Elderen; Henk Tijssen; P L C M van Riel; L B A Van De Putte
No support for HLA-DQ encoded susceptibility in rheumatoid arthritis.
Arthritis and rheumatism 1999;42(8):1621-7.
1999: P A te Boekhorst; Pilar Barrera; R F J M Laan; L B A Van De Putte
Hepatotoxicity of parenteral gold therapy in rheumatoid arthritis: a case report and review of the literature.
Clinical and experimental rheumatology 1999;17(3):359-62.
1999: Pilar Barrera; Timothy Radstake; JM Albers; P L C M van Riel; L B A Van De Putte
Familial aggregation of rheumatoid arthritis in The Netherlands: a cross-sectional hospital-based survey. European Consortium on Rheumatoid Arthritis families (ECRAF).
Rheumatology (Oxford, England) 1999;38(5):415-22.
1999: JN Stolk; D G de Koning; A H Pennings; RA De Abreu; L B A Van De Putte; AM Boerbooms
Reduced purine 5'-nucleotidase activity in lymphocytes of patients with systemic lupus erythematosus: results of a pilot study.
Annals of the rheumatic diseases 1999;58(2):122-5.
1999: Cees Haagsma; Henk J Blom; P L C M van Riel; M A van't Hof; Belinda A J Giesendorf; D van Oppenraaij-Emmerzaal; L B A Van De Putte
Influence of sulphasalazine, methotrexate, and the combination of both on plasma homocysteine concentrations in patients with rheumatoid arthritis.
Annals of the rheumatic diseases 1999;58(2):79-84.
1999: Leo A B Joosten; Monique M A Helsen; Tore Saxne; D Heinegård; L B A Van De Putte; Wim B van den Berg
Synergistic protection against cartilage destruction by low dose prednisolone and interleukin-10 in established murine collagen arthritis.
Inflammation research : official journal of the European Histamine Research Society ... [et al.] 1999;48(1):48-55.
1998: RJ Rodenburg; F H J van den Hoogen; L B A Van De Putte; Walther J van Venrooij
Peripheral blood monocytes of rheumatoid arthritis patients do not express elevated TNF alpha, IL-1beta, and IL-8 mRNA levels. A comparison of monocyte isolation procedures.
Journal of immunological methods 1998;221(1-2):169-75.
1998: Tim Jansen; Pilar Barrera; B G van Engelen; N Cox; R F J M Laan; L B A Van De Putte
Dermatomyositis with subclinical myositis and spontaneous pneumomediastinum with pneumothorax: case report and review of the literature.
Clinical and experimental rheumatology 1998;16(6):733-5.
1998: A M M Eijsbouts; Frank van den Hoogen; R F J M Laan; Maarten C de Waal Malefijt; A Hermus; C Sweep; D J de Rooij; L B A Van De Putte
Similar response of adrenocorticotrophic hormone, cortisol and prolactin to surgery in rheumatoid arthritis and osteoarthritis.
British journal of rheumatology 1998;37(10):1138-9.
1998: JN Stolk; AM Boerbooms; RA De Abreu; D G de Koning; H J van Beusekom; W H Muller; L B A Van De Putte
Reduced thiopurine methyltransferase activity and development of side effects of azathioprine treatment in patients with rheumatoid arthritis.
Arthritis and rheumatism 1998;41(10):1858-66.
1998: L B A Van De Putte; Anke M van Gestel; P L C M van Riel
Early treatment of rheumatoid arthritis: rationale, evidence, and implications.
Annals of the rheumatic diseases 1998;57(9):511-2.
1998: P L E M van Lent; A E M Holthuysen; N Van Rooijen; L B A Van De Putte; Wim B van den Berg
Local removal of phagocytic synovial lining cells by clodronate-liposomes decreases cartilage destruction during collagen type II arthritis.
Annals of the rheumatic diseases 1998;57(7):408-13.
1998: Tim Jansen; H A van Heereveld; R F J M Laan; Pilar Barrera; L B A Van De Putte
Septic arthritis with Listeria monocytogenes during low-dose methotrexate.
Journal of internal medicine 1998;244(1):87-90.
1998: Pilar Barrera; Alfons A den Broeder; F H J van den Hoogen; B G van Engelen; L B A Van De Putte
Postural changes, dysphagia, and systemic sclerosis.
Annals of the rheumatic diseases 1998;57(6):331-8.
1998: P L E M van Lent; A E M Holthuysen; N van Rooijen; Fons A J van de Loo; L B A Van De Putte; Wim B van den Berg
Phagocytic synovial lining cells regulate acute and chronic joint inflammation after antigenic exacerbation of smouldering experimental murine arthritis.
The Journal of rheumatology 1998;25(6):1135-45.
1998: RJ Rodenburg; R F Brinkhuis; Ron Peek; J R Westphal; F H J van den Hoogen; Walther J van Venrooij; L B A Van De Putte
Expression of macrophage-derived chemokine (MDC) mRNA in macrophages is enhanced by interleukin-1beta, tumor necrosis factor alpha, and lipopolysaccharide.
Journal of leukocyte biology 1998;63(5):606-11.
1998: Annelies van Ede; R F J M Laan; Henk J Blom; R A De Abreu; L B A Van De Putte
Methotrexate in rheumatoid arthritis: an update with focus on mechanisms involved in toxicity.
Seminars in arthritis and rheumatism 1998;27(5):277-92.
1998: JN Stolk; AM Boerbooms; RA De Abreu; L B A Van De Putte
Azathioprine treatment and thiopurine metabolism in rheumatic diseases. Introduction and first results of investigation.
Advances in experimental medicine and biology 1998;431():487-93.
1998: GA Schellekens; Brigit A de Jong; F H J van den Hoogen; L B A Van De Putte; Walther J van Venrooij
Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies.
The Journal of clinical investigation 1998;101(1):273-81.
1997: Cees Haagsma; P L C M van Riel; A J de Jong; L B A Van De Putte
Combination of sulphasalazine and methotrexate versus the single components in early rheumatoid arthritis: a randomized, controlled, double-blind, 52 week clinical trial.
British journal of rheumatology 1997;36(10):1082-8.
1997: L B A Van De Putte; P L C M van Riel
Currently used second-line agents: do they control the disease course?
Clinical and experimental rheumatology 1997;15 Suppl 17():S71-4.
1997: L B A Van De Putte; Alan Tyndall; F H J van den Hoogen; J S Smolen
Hematopoietic stem cell transplants for autoimmune disease: role of EULAR. European League Against Rheumatism.
The Journal of rheumatology. Supplement 1997;48():98-9.
1997: M J Franssen; EB Koenders; AM Boerbooms; Wilhelmina C A M Buijs; J A Lemmens; L B A Van De Putte
Does application of radiographic contrast medium in radiation synovectomy influence the stability of Yttrium-90 colloid?
British journal of rheumatology 1997;36(4):506-8.
1997: Niek de Vries; Henk Tijssen; P Jarvinen; K Aho; L B A Van De Putte
HLA-DRB1 in eight Finnish monozygotic twin pairs concordant for rheumatoid arthritis.
Tissue antigens 1997;49(3 Pt 1):277-9.
1997: P L E M van Lent; A Blom; A E M Holthuysen; C W Jacobs; L B A Van De Putte; Wim B van den Berg
Monocytes/macrophages rather than PMN are involved in early cartilage degradation in cationic immune complex arthritis in mice.
Journal of leukocyte biology 1997;61(3):267-78.
1997: Miek A van Leeuwen; Martin H van Rijswijk; W J Sluiter; P L C M van Riel; IH Kuper; L B A Van De Putte; M B Pepys; Pieter C Limburg
Individual relationship between progression of radiological damage and the acute phase response in early rheumatoid arthritis. Towards development of a decision support system.
The Journal of rheumatology 1997;24(1):20-7.
1996: ML Prevoo; Anke M van Gestel; M A van T Hof; Martin H van Rijswijk; L B A Van De Putte; P L C M van Riel
Remission in a prospective study of patients with rheumatoid arthritis. American Rheumatism Association preliminary remission criteria in relation to the disease activity score.
British journal of rheumatology 1996;35(11):1101-5.
1996: J N Stolk; AM Boerbooms; Ronney A De Abreu; P J Kerstens; D G de Koning; R de Graaf; J Mulder; L B A Van De Putte
Purine enzyme activities in recent onset rheumatoid arthritis: are there differences between patients and healthy controls?
Annals of the rheumatic diseases 1996;55(10):733-8.
1996: P L E M van Lent; A E M Holthuysen; L A van den Bersselaar; N van Rooijen; Leo A B Joosten; Fons A J van de Loo; L B A Van De Putte; Wim B van den Berg
Phagocytic lining cells determine local expression of inflammation in type II collagen-induced arthritis.
Arthritis and rheumatism 1996;39(9):1545-55.
1996: P L C M van Riel; Anke M van Gestel; L B A Van De Putte
Development and validation of response criteria in rheumatoid arthritis: steps towards an international consensus on prognostic markers.
British journal of rheumatology 1996;35 Suppl 2():4-7.
1996: M C Creemers; M A van 't Hof; M J Franssen; L B A Van De Putte; F W Gribnau; P L C M van Riel
Disease activity in ankylosing spondylitis: selection of a core set of variables and a first set in the development of a disease activity score.
British journal of rheumatology 1996;35(9):867-73.
1996: C J Haagsma; F G Russel; T B Vree; P L Van Riel; L B A Van De Putte
Combination of methotrexate and sulphasalazine in patients with rheumatoid arthritis: pharmacokinetic analysis and relationship to clinical response.
British journal of clinical pharmacology 1996;42(2):195-200.
1996: ML Prevoo; I H Kuper; M A van't Hof; Miek A van Leeuwen; L B A Van De Putte; P L C M van Riel
Validity and reproducibility of self-administered joint counts. A prospective longitudinal followup study in patients with rheumatoid arthritis.
The Journal of rheumatology 1996;23(5):841-5.
1996: Peter C M de Wilde; L Kater; C Bodeutsch; F H van den Hoogen; L B A Van De Putte; W J van Venrooij
Aberrant expression pattern of the SS-B/La antigen in the labial salivary glands of patients with Sjögren's syndrome.
Arthritis and rheumatism 1996;39(5):783-91.
1996: F H J van den Hoogen; AM Boerbooms; A J Swaak; Johannes J Rasker; H J van Lier; L B A Van De Putte
Comparison of methotrexate with placebo in the treatment of systemic sclerosis: a 24 week randomized double-blind trial, followed by a 24 week observational trial.
British journal of rheumatology 1996;35(4):364-72.
1996: Pilar Barrera; AM Boerbooms; L B A Van De Putte; J W van der Meer
Effects of antirheumatic agents on cytokines.
Seminars in arthritis and rheumatism 1996;25(4):234-53.
1996: Anke M van Gestel; ML Prevoo; M A van 't Hof; Martin H van Rijswijk; L B A Van De Putte; P L C M van Riel
Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism Criteria.
Arthritis and rheumatism 1996;39(1):34-40.
1995: P L C M van Riel; Anke M van Gestel; L B A Van De Putte
Long-term usage and side-effect profile of sulphasalazine in rheumatoid arthritis.
British journal of rheumatology 1995;34 Suppl 2():40-2.
1995: Cees Haagsma; P L C M van Riel; L B A Van De Putte
Combining sulphasalazine and methotrexate in rheumatoid arthritis: early clinical impressions.
British journal of rheumatology 1995;34 Suppl 2():104-8.
1995: L B A Van De Putte; P L C M van Riel
Rheumatoid arthritis--changing theories and treatment modalities.
Acta orthopaedica Scandinavica. Supplementum 1995;266():10-3.
1995: L B A Van De Putte; P L C M van Riel
Rheumatoid arthritis: new trends in therapy.
Clinical and experimental rheumatology 1995;13 Suppl 12():S27-30.
1995: P L C M van Riel; Désirée van der Heijde; I H Nuver-Zwart; L B A Van De Putte
Radiographic progression in rheumatoid arthritis: results of 3 comparative trials.
The Journal of rheumatology 1995;22(9):1797-9.
1995: Désirée van der Heijde; Miek A van Leeuwen; P L C M van Riel; L B A Van De Putte
Radiographic progression on radiographs of hands and feet during the first 3 years of rheumatoid arthritis measured according to Sharp's method (van der Heijde modification).
The Journal of rheumatology 1995;22(9):1792-6.
1995: Pilar Barrera; Cees Haagsma; AM Boerbooms; P L C M van Riel; G F Borm; L B A Van De Putte; J W Van der Meer
Effect of methotrexate alone or in combination with sulphasalazine on the production and circulating concentrations of cytokines and their antagonists. Longitudinal evaluation in patients with rheumatoid arthritis.
British journal of rheumatology 1995;34(8):747-55.
1995: M C Creemers; M J Franssen; L B A Van De Putte; F W Gribnau; P L C M van Riel
Methotrexate in severe ankylosing spondylitis: an open study.
The Journal of rheumatology 1995;22(6):1104-7.
1995: AM Boerbooms; P J Kerstens; J W van Loenhout; J Mulder; L B A Van De Putte
Infections during low-dose methotrexate treatment in rheumatoid arthritis.
Seminars in arthritis and rheumatism 1995;24(6):411-21.
1995: J N Stolk; Ronney A De Abreu; AM Boerbooms; D G de Koning; R de Graaf; P J Kerstens; L B A Van De Putte
Purine enzyme activities in peripheral blood mononuclear cells: comparison of a new non-radiochemical high-performance liquid chromatography procedure and a radiochemical thin-layer chromatography procedure.
Journal of chromatography. B, Biomedical applications 1995;666(1):33-43.
1995: Anke M van Gestel; R F J M Laan; Cees Haagsma; L B A Van De Putte; P L C M van Riel
Oral steroids as bridge therapy in rheumatoid arthritis patients starting with parenteral gold. A randomized double-blind placebo-controlled trial.
British journal of rheumatology 1995;34(4):347-51.
1995: ML Prevoo; M A van 't Hof; H H Kuper; Miek A van Leeuwen; L B A Van De Putte; P L C M van Riel
Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis.
Arthritis and rheumatism 1995;38(1):44-8.
1995: P J Kerstens; J N Stolk; Ronney A De Abreu; Lambert H J Lambooy; L B A Van De Putte; A A Boerbooms
Azathioprine-related bone marrow toxicity and low activities of purine enzymes in patients with rheumatoid arthritis.
Arthritis and rheumatism 1995;38(1):142-5.
1995: P J Kerstens; J N Stolk; AM Boerbooms; Ronney A De Abreu; L B A Van De Putte
Purine enzymes in rheumatoid arthritis. A clue to the prediction of the response to azathioprine? Review and hypothesis.
Clinical and experimental rheumatology 1995;13(1):107-11.
1995: P L E M van Lent; A E M Holthuysen; L van den Bersselaar; N van Rooijen; L B A Van De Putte; Wim B van den Berg
Role of macrophage-like synovial lining cells in localization and expression of experimental arthritis.
Scandinavian journal of rheumatology. Supplement 1995;101():83-9.
1995: L B A Van De Putte
Chronic arthritis: why the joint?
Scandinavian journal of rheumatology. Supplement 1995;101():7-9.
1994: F H J van den Hoogen; P E Spronk; AM Boerbooms; Hendrika Bootsma; D J de Rooij; Cees G M Kallenberg; L B A Van De Putte
Long-term follow-up of 46 patients with anti-(U1)snRNP antibodies.
British journal of rheumatology 1994;33(12):1117-20.
1994: P J Kerstens; AM Boerbooms; M E Jeurissen; T A Westgeest; A Van Erp; J Mulder; L B A Van De Putte
Antiperinuclear factor and disease activity in rheumatoid arthritis. Longitudinal evaluation during methotrexate and azathioprine therapy.
The Journal of rheumatology 1994;21(12):2190-4.
1994: W van Lankveld; P van't Pad Bosch; L B A Van De Putte; Gérard Näring; C van der Staak
Disease-specific stressors in rheumatoid arthritis: coping and well-being.
British journal of rheumatology 1994;33(11):1067-73.
1994: Cees Haagsma; P L C M van Riel; D J de Rooij; T B Vree; F J Russel; M A van't Hof; L B A Van De Putte
Combination of methotrexate and sulphasalazine vs methotrexate alone: a randomized open clinical trial in rheumatoid arthritis patients resistant to sulphasalazine therapy.
British journal of rheumatology 1994;33(11):1049-55.
1994: Pilar Barrera; AM Boerbooms; Pierre N M Demacker; L B A Van De Putte; H Gallati; J W van der Meer
Circulating concentrations and production of cytokines and soluble receptors in rheumatoid arthritis patients: effects of a single dose methotrexate.
British journal of rheumatology 1994;33(11):1017-24.
1994: M J Jacobs; A E van den Hoek; P L E M van Lent; Fons A J van de Loo; L B A Van De Putte; Wim B van den Berg
Role of IL-2 and IL-4 in exacerbations of murine antigen-induced arthritis.
Immunology 1994;83(3):390-6.
1994: M C Creemers; P L C M van Riel; M J Franssen; L B A Van De Putte; F W Gribnau
Second-line treatment in seronegative spondylarthropathies.
Seminars in arthritis and rheumatism 1994;24(2):71-81.
1994: Anke M van Gestel; R Koopman; M Wijnands; L B A Van De Putte; P L C M van Riel
Mucocutaneous reactions to gold: a prospective study of 74 patients with rheumatoid arthritis.
The Journal of rheumatology 1994;21(10):1814-9.
1994: M C Creemers; M A Van 't Hof; M J Franssen; L B A Van De Putte; F W Gribnau; P L C M van Riel
A Dutch version of the functional index for ankylosing spondylitis: development and validation in a long-term study.
British journal of rheumatology 1994;33(9):842-6.
1994: P J Kerstens; J N Stolk; AM Boerbooms; Lambert H J Lambooy; R de Graaf; Ronney A De Abreu; L B A Van De Putte
Purine enzymes in rheumatoid arthritis: possible association with response to azathioprine. A pilot study.
Annals of the rheumatic diseases 1994;53(9):608-11.
1994: P L van Riel; L B A Van De Putte
DC-ART: what proportion of response constitutes a positive response?
The Journal of rheumatology. Supplement 1994;41():54-5; discussion 56.
1994: Pilar Barrera; A Van Ede; R F J M Laan; P L C M van Riel; AM Boerbooms; L B A Van De Putte
Methotrexate-related pulmonary complications in patients with rheumatoid arthritis: cluster of five cases in a period of three months.
Annals of the rheumatic diseases 1994;53(7):479-80.
1994: Pilar Barrera; R F J M Laan; P L C M van Riel; P N Dekhuijzen; AM Boerbooms; L B A Van De Putte
Methotrexate-related pulmonary complications in rheumatoid arthritis.
Annals of the rheumatic diseases 1994;53(7):434-9.
1994: P J Kerstens; AM Boerbooms; E P Brummelkamp; L B A Van De Putte
Long-term methotrexate in refractory rheumatoid arthritis; concurrent use of prednisone possibly improves drug-survival.
Clinical rheumatology 1994;13(2):317-8.
1994: J R Westphal; A M Boerbooms; C J Schalwijk; H Kwast; M De Weijert; C Jacobs; G Vierwinden; D J Ruiter; L B A Van De Putte; Robert M W de Waal
Anti-endothelial cell antibodies in sera of patients with autoimmune diseases: comparison between ELISA and FACS analysis.
Clinical and experimental immunology 1994;96(3):444-9.
1994: M J Jacobs; A E van den Hoek; L B A Van De Putte; Wim B van den Berg
Anergy of antigen-specific T lymphocytes is a potent mechanism of intravenously induced tolerance.
Immunology 1994;82(2):294-300.
1994: M J Jacobs; A E van den Hoek; L B A Van De Putte; Wim B van den Berg
Suppression of hen egg lysozyme-induced arthritis by intravenous antigen administration: no role in this for antigen-driven bystander suppression.
Clinical and experimental immunology 1994;96(1):36-42.
1994: Pilar Barrera; AM Boerbooms; R W Sauerwein; Pierre N M Demacker; L B A Van De Putte; J W van der Meer
Interference of circulating azathioprine but not methotrexate or sulfasalazine with measurements of interleukin-6 bioactivity.
Lymphokine and cytokine research 1994;13(2):155-9.
1994: Miek A van Leeuwen; Désirée van der Heijde; Martin H van Rijswijk; Pieternella Houtman; P L C M van Riel; L B A Van De Putte; Pieter C Limburg
Interrelationship of outcome measures and process variables in early rheumatoid arthritis. A comparison of radiologic damage, physical disability, joint counts, and acute phase reactants.
The Journal of rheumatology 1994;21(3):425-9.
1994: P L E M van Lent; A E van den Hoek; L A van den Bersselaar; Fons A J van de Loo; H E Eykholt; W F Brouwer; L B A Van De Putte; Wim B van den Berg
Early cartilage degradation in cationic immune complex arthritis in mice: relative role of interleukin 1, the polymorphonuclear cell (PMN) and PMN elastase.
The Journal of rheumatology 1994;21(2):321-9.
1993: M J Jacobs; A E van den Hoek; L B A Van De Putte; Wim B van den Berg
Induction of tolerance by T-cell vaccination is possible beyond the area of autoimmunity: down-regulation of immunity directed to foreign protein antigens.
Immunology 1993;80(4):511-7.
1993: P J Lanting; M W Kruijsen; J J Rasher; F H van den Hoogen; AM Boerbooms; L B A Van De Putte
Severe intestinal pseudoobstruction in a patient with systemic sclerosis. Successful treatment with octreotide.
The Journal of rheumatology 1993;20(12):2175.
1993: R F J M Laan; P L C M van Riel; L B A Van De Putte; L J van Erning; M A van't Hof; J Albert M Lemmens
Low-dose prednisone induces rapid reversible axial bone loss in patients with rheumatoid arthritis. A randomized, controlled study.
Annals of internal medicine 1993;119(10):963-8.
1993: P J Kerstens; J N Stolk; L B Hilbrands; L B A Van De Putte; Ronney A De Abreu; AM Boerbooms
5-nucleotidase and azathioprine-related bone-marrow toxicity.
Lancet 1993;342(8881):1245-6.
1993: M J Wijnands; M A Van 't Hof; Miek A van Leeuwen; Martin H van Rijswijk; L B A Van De Putte; P L C M van Riel
A prospective analysis of risk factors for the discontinuation of second-line antirheumatic drugs.
Pharmacy world & science : PWS 1993;15(5):203-7.
1993: A G van de Langerijt; P L E M van Lent; A R Hermus; L B A Van De Putte; Wim B van den Berg
Regulation of resistance against adjuvant arthritis in the Fisher rat.
Clinical and experimental immunology 1993;94(1):150-5.
1993: F H J van den Hoogen; Peter van der Kraan; AM Boerbooms; Wim B van den Berg; H J van Lier; L B A Van De Putte
Effects of methotrexate on glycosaminoglycan production by scleroderma fibroblasts in culture.
Annals of the rheumatic diseases 1993;52(10):758-61.
1993: P L E M van Lent; A E Van den Hoek; L A Van den Bersselaar; M F Spanjaards; N Van Rooijen; C D Dijkstra; L B A Van De Putte; Wim B van den Berg
In vivo role of phagocytic synovial lining cells in onset of experimental arthritis.
The American journal of pathology 1993;143(4):1226-37.
1993: Pilar Barrera; AM Boerbooms; E M Janssen; R W Sauerwein; H Gallati; J Mulder; T de Boo; Pierre N M Demacker; L B A Van De Putte; J W van der Meer
Circulating soluble tumor necrosis factor receptors, interleukin-2 receptors, tumor necrosis factor alpha, and interleukin-6 levels in rheumatoid arthritis. Longitudinal evaluation during methotrexate and azathioprine therapy.
Arthritis and rheumatism 1993;36(8):1070-9.
1993: ML Prevoo; P L C M van Riel; M A van 't Hof; Martin H van Rijswijk; Miek A van Leeuwen; H H Kuper; L B A Van De Putte
Validity and reliability of joint indices. A longitudinal study in patients with recent onset rheumatoid arthritis.
British journal of rheumatology 1993;32(7):589-94.
1993: Miek A van Leeuwen; Martin H van Rijswijk; Désirée van der Heijde; Gerard te Meerman; P L C M van Riel; Pieternella Houtman; L B A Van De Putte; Pieter C Limburg
The acute-phase response in relation to radiographic progression in early rheumatoid arthritis: a prospective study during the first three years of the disease.
British journal of rheumatology 1993;32 Suppl 3():9-13.
1993: W van Lankveld; Gérard Näring; C van der Staak; P van 't Pad Bosch; L B A Van De Putte
Stress caused by rheumatoid arthritis: relation among subjective stressors of the disease, disease status, and well-being.
Journal of behavioral medicine 1993;16(3):309-21.
1993: Niek de Vries; C F Prinsen; E B Mensink; P L van Riel; M A van't Hof; L B A Van De Putte
A T cell receptor beta chain variable region polymorphism associated with radiographic progression in rheumatoid arthritis.
Annals of the rheumatic diseases 1993;52(5):327-31.
1993: Niek de Vries; Jules P P Meijerink; Henk Tijssen; M Demas; E J Mensink; L B A Van De Putte
A novel HLA-DPB1 allele (DPB1*4501) in a Dutch Caucasian healthy control.
Tissue antigens 1993;41(5):255-8.
1993: M J Wijnands; M A Van 'T Hof; L B A Van De Putte; P L C M van Riel
Rheumatoid arthritis: a risk factor for sulphasalazine toxicity? A meta-analysis.
British journal of rheumatology 1993;32(4):313-8.
1993: Désirée van der Heijde; M van 't Hof; P L C M van Riel; L B A Van De Putte
Development of a disease activity score based on judgment in clinical practice by rheumatologists.
The Journal of rheumatology 1993;20(3):579-81.
1993: L B A Van De Putte; AM Boerbooms; Pilar Barrera; P J Kerstens; M E Jeurissen
Methotrexate: anti-inflammatory or immunosuppressive?
Clinical and experimental rheumatology 1993;11 Suppl 8():S97-9.
1993: C Bodeutsch; Peter C M de Wilde; L Kater; F H van den Hoogen; R J Hené; J C van Houwelingen; L B A Van De Putte; G Peter Vooijs
Monotypic plasma cells in labial salivary glands of patients with Sjögren's syndrome: prognosticator for systemic lymphoproliferative disease.
Journal of clinical pathology 1993;46(2):123-8.
1993: P L E M van Lent; L van den Bersselaar; A E van den Hoek; M van de Ende; C D Dijkstra; N van Rooijen; L B A Van De Putte; Wim B van den Berg
Reversible depletion of synovial lining cells after intra-articular treatment with liposome-encapsulated dichloromethylene diphosphonate.
Rheumatology international 1993;13(1):21-30.
1993: Niek de Vries; K S Rønningen; M G Tilanus; A Bouwens-Rombouts; R Segal; T Egeland; E Thorsby; L B A Van De Putte; C Brautbar
HLA-DR1 and rheumatoid arthritis in Israeli Jews: sequencing reveals that DRB1*0102 is the predominant HLA-DR1 subtype.
Tissue antigens 1993;41(1):26-30.
1993: R F J M Laan; Wilhelmina C A M Buijs; L J van Erning; J Albert M Lemmens; F H Corstens; SH Ruijs; L B A Van De Putte; P L C M van Riel
Differential effects of glucocorticoids on cortical appendicular and cortical vertebral bone mineral content.
Calcified tissue international 1993;52(1):5-9.
1993: R F J M Laan; Wilhelmina C A M Buijs; André L M Verbeek; M P Draad; Frans H M Corstens; L B A Van De Putte; P L C M van Riel
Bone mineral density in patients with recent onset rheumatoid arthritis: influence of disease activity and functional capacity.
Annals of the rheumatic diseases 1993;52(1):21-6.
1993: M J Jacobs; A E van den Hoek; L B A Van De Putte; Wim B van den Berg
Aberrant tolerance induction with cationic antigens.
Scandinavian journal of immunology 1993;37(1):97-103.
1992: P J Kerstens; J W Van Loenhout; AM Boerbooms; L B A Van De Putte
Methotrexate, pneumonitis, and infection.
Annals of the rheumatic diseases 1992;51(10):1179; author reply 1179-80.
1992: R F J M Laan; L J van Erning; J Albert M Lemmens; L B A Van De Putte; SH Ruijs; P L C M van Riel
Single- versus dual-energy quantitative computed tomography for spinal densitometry in patients with rheumatoid arthritis.
The British journal of radiology 1992;65(778):901-4.
1992: René M A Hoet; I Koornneef; D J de Rooij; L B A Van De Putte; Walther J van Venrooij
Changes in anti-U1 RNA antibody levels correlate with disease activity in patients with systemic lupus erythematosus overlap syndrome.
Arthritis and rheumatism 1992;35(10):1202-10.
1992: C Bodeutsch; Peter C M de Wilde; L Kater; J C van Houwelingen; F H van den Hoogen; Aike A Kruize; R J Hené; L B A Van De Putte; G Peter Vooijs
Quantitative immunohistologic criteria are superior to the lymphocytic focus score criterion for the diagnosis of Sjögren's syndrome.
Arthritis and rheumatism 1992;35(9):1075-87.
1992: Désirée van der Heijde; P L C M van Riel; Miek A van Leeuwen; M A van 't Hof; Martin H van Rijswijk; L B A Van De Putte
Prognostic factors for radiographic damage and physical disability in early rheumatoid arthritis. A prospective follow-up study of 147 patients.
British journal of rheumatology 1992;31(8):519-25.
1992: W van Lankveld; P van 't Pad Bosch; L B A Van De Putte; C van der Staak; Gérard Näring
[Pain in rheumatoid arthritis measured with the visual analogue scale and the Dutch version of the McGill Pain Questionnaire].
Nederlands tijdschrift voor geneeskunde 1992;136(24):1166-70.
1992: R F J M Laan; P L C M van Riel; L B A Van De Putte
Bone mass in patients with rheumatoid arthritis.
Annals of the rheumatic diseases 1992;51(6):826-32.
1992: C Bodeutsch; Peter C M de Wilde; L Kater; F H van den Hoogen; Aike A Kruize; G P Ebben; H M Kerstens; L B A Van De Putte; G Peter Vooijs
Quantitative immunohistologic study of lip biopsies. Evaluation of diagnostic and prognostic value in Sjögren's syndrome.
Pathology, research and practice 1992;188(4-5):599-602.
1992: P J Kerstens; AM Boerbooms; M E Jeurissen; J H Fast; K J Assmann; L B A Van De Putte
Accelerated nodulosis during low dose methotrexate therapy for rheumatoid arthritis. An analysis of ten cases.
The Journal of rheumatology 1992;19(6):867-71.
1992: C Bodeutsch; Peter C M de Wilde; L Kater; R J Hené; F H van den Hoogen; L B A Van De Putte; G Peter Vooijs
Labial salivary gland biopsy in Sjögren's syndrome.
The Netherlands journal of medicine 1992;40(3-4):148-57.
1992: M J Wijnands; M A van't Hof; Miek A van Leeuwen; Martin H van Rijswijk; L B A Van De Putte; P L C M van Riel
Long-term second-line treatment: a prospective drug survival study.
British journal of rheumatology 1992;31(4):253-8.
1992: R F J M Laan; P L C M van Riel; L J van Erning; J Albert M Lemmens; SH Ruijs; L B A Van De Putte
Vertebral osteoporosis in rheumatoid arthritis patients: effect of low dose prednisone therapy.
British journal of rheumatology 1992;31(2):91-6.
1992: Désirée van der Heijde; M A van't Hof; P L C M van Riel; Miek A van Leeuwen; Martin H van Rijswijk; L B A Van De Putte
Validity of single variables and composite indices for measuring disease activity in rheumatoid arthritis.
Annals of the rheumatic diseases 1992;51(2):177-81.
1992: Désirée van der Heijde; Miek A van Leeuwen; P L C M van Riel; A M Koster; M A van 't Hof; Martin H van Rijswijk; L B A Van De Putte
Biannual radiographic assessments of hands and feet in a three-year prospective followup of patients with early rheumatoid arthritis.
Arthritis and rheumatism 1992;35(1):26-34.
1991: Désirée van der Heijde; P L C M van Riel; Miek A van Leeuwen; M A van 't Hof; Martin H van Rijswijk; L B A Van De Putte
Older versus younger onset rheumatoid arthritis: results at onset and after 2 years of a prospective followup study of early rheumatoid arthritis.
The Journal of rheumatology 1991;18(9):1285-9.
1991: C Bodeutsch; Peter C M de Wilde; J C van Houwelingen; G P Ebben; H M Kerstens; L Kater; L B A Van De Putte; G Peter Vooijs
Influence of fixation and immunohistological technique on accuracy, precision and inter-observer reproducibility of plasma cell counting.
Analytical cellular pathology : the journal of the European Society for Analytical Cellular Pathology 1991;3(5):299-310.
1991: M E Jeurissen; AM Boerbooms; L B A Van De Putte; W H Doesburg; J Mulder; Johannes J Rasker; M W Kruijsen; J F Haverman; H J van Beusekom; W H Muller
Methotrexate versus azathioprine in the treatment of rheumatoid arthritis. A forty-eight-week randomized, double-blind trial.
Arthritis and rheumatism 1991;34(8):961-72.
1991: M E Jeurissen; AM Boerbooms; L B A Van De Putte; W H Doesburg; A M Lemmens
Influence of methotrexate and azathioprine on radiologic progression in rheumatoid arthritis. A randomized, double-blind study.
Annals of internal medicine 1991;114(12):999-1004.
1991: C Bodeutsch; Peter C M de Wilde; L Kater; F H van den Hoogen; A J de Jong; W A Borstlap; L B A Van De Putte; G Peter Vooijs
Diagnostic and prognostic value of quantitative immunohistological examination of lip biopsy in Sjögren's syndrome.
The Netherlands journal of medicine 1991;38(3-4):110-6.
1991: M Wijnands; P L C M van Riel; M van 't Hof; F Gribnau; L B A Van De Putte
Longterm treatment with nonsteroidal antiinflammatory drugs in rheumatoid arthritis: a prospective drug survival study.
The Journal of rheumatology 1991;18(2):184-7.
1991: J W G Jacobs; Johannes J Rasker; P L C M van Riel; F W Gribnau; L B A Van De Putte
Rheumajecta and vasolastine in the treatment of rheumatoid arthritis--the results of a placebo-controlled, double-blind trial of a complementary treatment.
Scandinavian journal of rheumatology 1991;20(6):434-40.
1991: M J Wijnands; I H Nuver-Zwart; P L C M van Riel; M A van 't Hof; F W Gribnau; L B A Van De Putte
Hemolysis during low-dose sulfasalazine treatment in rheumatoid arthritis patients.
Scandinavian journal of rheumatology 1991;20(1):52-7.
1990: Walther J van Venrooij; René M A Hoet; J Castrop; B Hageman; Iain W Mattaj; L B A Van De Putte
Anti-(U1) small nuclear RNA antibodies in anti-small nuclear ribonucleoprotein sera from patients with connective tissue diseases.
The Journal of clinical investigation 1990;86(6):2154-60.
1990: Désirée van der Heijde; M A van 't Hof; P L C M van Riel; L A Theunisse; Erik Lubberts; Miek A van Leeuwen; Martin H van Rijswijk; L B A Van De Putte
Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score.
Annals of the rheumatic diseases 1990;49(11):916-20.
1990: M J Wijnands; W A Allebes; A M Boerbooms; L B A Van De Putte; P L van Riel
Thrombocytopenia due to aurothioglucose, sulphasalazine, and hydroxychloroquine.
Annals of the rheumatic diseases 1990;49(10):798-800.
1990: F H van den Hoogen; AM Boerbooms; L B A Van De Putte
Effects of immunomodulating therapy in systemic sclerosis.
Clinical rheumatology 1990;9(3):319-24.
1990: Joost Schalkwijk; Leo A B Joosten; Wim B van den Berg; L B A Van De Putte
Antigen induced arthritis in beige (Chediak-Higashi) mice.
Annals of the rheumatic diseases 1990;49(8):607-10.
1990: M J Wijnands; P L C M van Riel; F W Gribnau; L B A Van De Putte
[Risk factors for the development of side effects during treatment of rheumatoid arthritis with second-line antirheumatic agents; a review of the literature].
Nederlands tijdschrift voor geneeskunde 1990;134(29):1387-91.
1990: D J de Rooij; W J Habets; L B A Van De Putte; M H Hoet; André L M Verbeek; Walther J van Venrooij
Use of recombinant RNP peptides 70K and A in an ELISA for measurement of antibodies in mixed connective tissue disease: a longitudinal follow up of 18 patients.
Annals of the rheumatic diseases 1990;49(6):391-5.
1990: P L E M van Lent; L van den Bersselaar; L B A Van De Putte; Wim B van den Berg
Immobilization aggravates cartilage damage during antigen-induced arthritis in mice. Attachment of polymorphonuclear leukocytes to articular cartilage.
The American journal of pathology 1990;136(6):1407-16.
1990: M J Wijnands; P L C M van Riel; F W Gribnau; L B A Van De Putte
Risk factors of second-line antirheumatic drugs in rheumatoid arthritis.
Seminars in arthritis and rheumatism 1990;19(6):337-52.
1990: A A Westgeest; AM Boerbooms; L B A Van De Putte
The influence of serum dilution on findings of antiperinuclear factor prevalence in rheumatoid arthritis.
Arthritis and rheumatism 1990;33(5):759-60.
1990: M J Wijnands; C M Perret; F H van den Hoogen; L B A Van De Putte; P L C M van Riel
Chrysotherapy provoking exacerbation of contact hypersensitivity to nickel.
Lancet 1990;335(8693):867-8.
1990: Désirée van der Heijde; P L C M van Riel; I H Nuver-Zwart; L B A Van De Putte
Sulphasalazine versus hydroxychloroquine in rheumatoid arthritis: 3-year follow-up.
Lancet 1990;335(8688):539.
1990: Peter van der Kraan; Elly L Vitters; B J de Vries; Wim B van den Berg; L B A Van De Putte
The effect of chronic paracetamol administration to rats on the glycosaminoglycan content of patellar cartilage.
Agents and actions 1990;29(3-4):218-23.
1990: M F van den Broek; M C van Bruggen; S A Stimpson; A J Severijnen; L B A Van De Putte; Wim B van den Berg
Flare-up reaction of streptococcal cell wall induced arthritis in Lewis and F344 rats: the role of T lymphocytes.
Clinical and experimental immunology 1990;79(2):297-306.
1990: Peter van der Kraan; Elly L Vitters; Henk M van Beuningen; L B A Van De Putte; Wim B van den Berg
Degenerative knee joint lesions in mice after a single intra-articular collagenase injection. A new model of osteoarthritis.
Journal of experimental pathology (Oxford, England) 1990;71(1):19-31.
1990: AM Boerbooms; A A Westgeest; P Reekers; L B A Van De Putte
Immunogenetic heterogeneity of seronegative rheumatoid arthritis and the antiperinuclear factor.
Annals of the rheumatic diseases 1990;49(1):15-7.
1990: M J Wijnands; C M Perret; P L C M van Riel; L B A Van De Putte
Generalized urticarial eruption during azathioprine treatment for rheumatoid arthritis. A case report and review of the literature.
Scandinavian journal of rheumatology 1990;19(2):167-9.
1990: M E Jeurissen; AM Boerbooms; L B A Van De Putte; M W Kruijsen
Azathioprine induced fever, chills, rash, and hepatotoxicity in rheumatoid arthritis.
Annals of the rheumatic diseases 1990;49(1):25-7.
1990: Désirée van der Heijde; P L C M van Riel; L B A Van De Putte
Sensitivity of a Dutch Health Assessment Questionnaire in a trial comparing hydroxychloroquine vs. sulphasalazine.
Scandinavian journal of rheumatology 1990;19(6):407-12.
1989: P Faaber; L A van den Bersselaar; L B A Van De Putte; Wim B van den Berg
Immune complex formation between IgM rheumatoid factor and IgG generated by hyaluronic acid.
Arthritis and rheumatism 1989;32(12):1521-7.
1989: M J Franssen; AM Boerbooms; R P Karthaus; Wilhelmina C A M Buijs; L B A Van De Putte
Treatment of pigmented villonodular synovitis of the knee with yttrium-90 silicate: prospective evaluations by arthroscopy, histology, and 99mTc pertechnetate uptake measurements.
Annals of the rheumatic diseases 1989;48(12):1007-13.
1989: Peter van der Kraan; Elly L Vitters; L B A Van De Putte; Wim B van den Berg
Development of osteoarthritic lesions in mice by "metabolic" and "mechanical" alterations in the knee joints.
The American journal of pathology 1989;135(6):1001-14.
1989: P Faaber; L A van den Bersselaar; L B A Van De Putte; Wim B van den Berg
Circulating immune complexes and rheumatoid arthritis: the induction of immune complex formation between rheumatoid factor and IgG by polyethylene glycol.
The Journal of rheumatology 1989;16(10):1304-9.
1989: M E Jeurissen; AM Boerbooms; L B A Van De Putte
Eruption of nodulosis and vasculitis during methotrexate therapy for rheumatoid arthritis.
Clinical rheumatology 1989;8(3):417-9.
1989: M E Jeurissen; AM Boerbooms; L B A Van De Putte
Pancytopenia and methotrexate with trimethoprim-sulfamethoxazole.
Annals of internal medicine 1989;111(3):261.
1989: M E Jeurissen; A M Boerbooms; L B A Van De Putte
Methotrexate therapy in connective tissue diseases: a review of the literature.
The Netherlands journal of medicine 1989;35(1-2):44-58.
1989: Joost Schalkwijk; Leo A B Joosten; Wim B van den Berg; L B A Van De Putte
Chondrocyte nonresponsiveness to insulin-like growth factor 1 in experimental arthritis.
Arthritis and rheumatism 1989;32(7):894-900.
1989: Henk M van Beuningen; Wim B van den Berg; Joost Schalkwijk; Onno J Arntz; L B A Van De Putte
Age- and sex-related differences in antigen-induced arthritis in C57Bl/10 mice.
Arthritis and rheumatism 1989;32(6):789-94.
1989: Walther J van Venrooij; K W Wodzig; W J Habets; D J de Rooij; L B A Van De Putte
Anti-56K: a novel, frequently occurring autoantibody specificity in connective tissue disease.
Clinical and experimental rheumatology 1989;7(3):277-82.
1989: I H Nuver-Zwart; P L C M van Riel; L B A Van De Putte; F W Gribnau
A double blind comparative study of sulphasalazine and hydroxychloroquine in rheumatoid arthritis: evidence of an earlier effect of sulphasalazine.
Annals of the rheumatic diseases 1989;48(5):389-95.
1989: A A Westgeest; A M van Loon; J T van der Logt; L B A Van De Putte; AM Boerbooms
Antiperinuclear factor, a rheumatoid arthritis specific autoantibody: its relation to Epstein-Barr virus.
The Journal of rheumatology 1989;16(5):626-30.
1989: W J Habets; M H Hoet; P T Sillekens; D J De Rooij; L B A Van De Putte; Walther J van Venrooij
Detection of autoantibodies in a quantitative immunoassay using recombinant ribonucleoprotein antigens.
Clinical and experimental immunology 1989;76(2):172-7.
1989: Joost Schalkwijk; Leo A B Joosten; Wim B van den Berg; Judson Vanwyk; L B A Van De Putte
Insulin-like growth factor stimulation of chondrocyte proteoglycan synthesis by human synovial fluid.
Arthritis and rheumatism 1989;32(1):66-71.
1989: Leo A B Joosten; Joost Schalkwijk; Wim B van den Berg; L B A Van De Putte
Chondrocyte unresponsiveness to insulin-like growth factor-1. A novel pathogenetic mechanisms for cartilage destruction in experimental arthritis.
Agents and actions 1989;26(1-2):193-5.
1989: Peter van der Kraan; B J de Vries; Elly L Vitters; Wim B van den Berg; L B A Van De Putte
The effect of low sulfate concentrations on the glycosaminoglycan synthesis in anatomically intact articular cartilage of the mouse.
Journal of orthopaedic research : official publication of the Orthopaedic Research Society 1989;7(5):645-53.
1988: Joost Schalkwijk; Leo A B Joosten; Wim B van den Berg; L B A Van De Putte
Experimental arthritis in C57black/6 normal and beige (Chediak-Higashi) mice: in vivo and in vitro observations on cartilage degradation.
Annals of the rheumatic diseases 1988;47(11):940-6.
1988: M F van den Broek; M C van Bruggen; L B A Van De Putte; Wim B van den Berg
T cell responses to streptococcal antigens in rats: relation to susceptibility to streptococcal cell wall-induced arthritis.
Cellular immunology 1988;116(1):216-29.
1988: Peter van der Kraan; B J de Vries; Elly L Vitters; Wim B van den Berg; L B A Van De Putte
Inhibition of glycosaminoglycan synthesis in anatomically intact rat patellar cartilage by paracetamol-induced serum sulfate depletion.
Biochemical pharmacology 1988;37(19):3683-90.
1988: M F van den Broek; Wim B van den Berg; L B A Van De Putte; A J Severijnen
Streptococcal cell wall-induced arthritis and flare-up reaction in mice induced by homologous or heterologous cell walls.
The American journal of pathology 1988;133(1):139-49.
1988: J M Wouters; J van der Veen; L B A Van De Putte; D J de Rooij
Adult onset Still's disease and viral infections.
Annals of the rheumatic diseases 1988;47(9):764-7.
1988: M F Van den Broek; L B A Van De Putte; Wim B van den Berg
Crohn's disease associated with arthritis: a possible role for cross-reactivity between gut bacteria and cartilage in the pathogenesis of arthritis.
Arthritis and rheumatism 1988;31(8):1077-9.
1988: AM Boerbooms; M E Jeurissen; A A Westgeest; H Theunisse; L B A Van De Putte
Methotrexate in refractory rheumatoid arthritis.
Clinical rheumatology 1988;7(2):249-56.
1988: M E Jeurissen; AM Boerbooms; L B A Van De Putte
Pancytopenia related to azathioprine in rheumatoid arthritis.
Annals of the rheumatic diseases 1988;47(6):503-5.
1988: AM Boerbooms; M E Jeurissen; L B A Van De Putte
Pulse methotrexate therapy in rheumatoid arthritis.
Annals of internal medicine 1988;108(6):905.
1988: Désirée van der Heijde; P L C M van Riel; Martin H van Rijswijk; L B A Van De Putte
Influence of prognostic features on the final outcome in rheumatoid arthritis: a review of the literature.
Seminars in arthritis and rheumatism 1988;17(4):284-92.
1988: M F van den Broek; Wim B van den Berg; Onno J Arntz; L B A Van De Putte
Reaction of bacterium-primed murine T cells to cartilage components: a clue for the pathogenesis of arthritis?
Clinical and experimental immunology 1988;72(1):9-14.
1988: M F van den Broek; Wim B van den Berg; L B A Van De Putte
The role of mast cells in antigen induced arthritis in mice.
The Journal of rheumatology 1988;15(4):544-51.
1988: F A Van den Ouweland; P A Jansen; Y Tan; L B A Van De Putte; C A Van Ginneken; F W Gribnau
Pharmacokinetics of high-dosage naproxen in elderly patients.
International journal of clinical pharmacology, therapy, and toxicology 1988;26(3):143-7.
1988: Peter van der Kraan; Elly L Vitters; B J de Vries; Wim B van den Berg; L B A Van De Putte
Synthesis of aberrant glycosaminoglycans during cartilage culture in 'sulfate free' medium.
Journal of biochemical and biophysical methods 1988;15(5):273-7.
1988: Henk M van Beuningen; Wim B van den Berg; Joost Schalkwijk; Onno J Arntz; L B A Van De Putte
Age-related changes in joint damage caused by antigen-induced arthritis in mice.
Agents and actions 1988;23(1-2):74-6.
1988: Peter van der Kraan; B J de Vries; Wim B van den Berg; Elly L Vitters; L B A Van De Putte
Effects of drug-mediated serum sulfate depletion on glycosaminoglycan synthesis.
Agents and actions 1988;23(1-2):55-7.
1988: B J de Vries; Wim B van den Berg; Elly L Vitters; L B A Van De Putte
The influence of antirheumatic drugs on basal and accelerated breakdown of articular proteoglycans.
Agents and actions 1988;23(1-2):52-4.
1988: J Schalkwijk; L A Joosten; Wim B van den Berg; L B A Van De Putte
Degradation of cartilage proteoglycans by elastase is dependent on charge-mediated interactions.
Rheumatology international 1988;8(1):27-33.
1988: B J de Vries; W B van den Berg; Elly L Vitters; L B A Van De Putte
Effects of NSAIDs on the metabolism of sulphated glycosaminoglycans in healthy and (post) arthritic murine articular cartilage.
Drugs 1988;35 Suppl 1():24-32.
1988: F A Van den Ouweland; F W Gribnau; C A Van Ginneken; Y Tan; L B A Van De Putte
Naproxen kinetics and disease activity in rheumatoid arthritis: a within-patient study.
Clinical pharmacology and therapeutics 1988;43(1):79-85.
1988: B J de Vries; Wim B van den Berg; Elly L Vitters; L B A Van De Putte
Effect of nonsteroidal antiinflammatory drugs on cartilage destruction in antigen induced arthritis in mice.
Scandinavian journal of rheumatology. Supplement 1988;77():23-8.
1988: P L E M van Lent; Wim B van den Berg; L B A Van De Putte; L van den Bersselaar
Electrical charge of a protein determines penetration and localization in hyaline articular cartilage. Quantitative and autoradiographic studies on cartilage of different species, including man.
Rheumatology international 1988;8(4):145-52.
1987: A A Westgeest; AM Boerbooms; M Jongmans; J P Vandenbroucke; G Vierwinden; L B A Van De Putte
Antiperinuclear factor: indicator of more severe disease in seronegative rheumatoid arthritis.
The Journal of rheumatology 1987;14(5):893-7.
1987: P L E M van Lent; Wim B van den Berg; Joost Schalkwijk; L B A Van De Putte; L van den Bersselaar
Allergic arthritis induced by cationic antigens: relationship of chronicity with antigen retention and T-cell reactivity.
Immunology 1987;62(2):265-72.
1987: M J Franssen; AM Boerbooms; L B A Van De Putte
Polychondritis and rheumatoid arthritis. Case report and review of the literature.
Clinical rheumatology 1987;6(3):453-7.
1987: P L E M van Lent; Wim B van den Berg; Joost Schalkwijk; L B A Van De Putte; L van den Bersselaar
The impact of protein size and charge on its retention in articular cartilage.
The Journal of rheumatology 1987;14(4):798-805.
1987: B J de Vries; Elly L Vitters; Wim B van den Berg; D Schram; L B A Van De Putte
Determination of small quantities of sulfate (0-12 nmol) in serum, urine, and cartilage of the mouse.
Analytical biochemistry 1987;163(2):408-17.
1987: F A van den Ouweland; M J Franssen; L B A Van De Putte; Y Tan; C A van Ginneken; F W Gribnau
Naproxen pharmacokinetics in patients with rheumatoid arthritis during active polyarticular inflammation.
British journal of clinical pharmacology 1987;23(2):189-93.
1987: F A van den Ouweland; F H Corstens; L B A Van De Putte; F W Gribnau
Gastrointestinal blood loss during treatment with naproxen for rheumatoid arthritis.
Scandinavian journal of rheumatology 1987;16(5):365-70.
1986: L B A Van De Putte; F Speerstra; P L van Riel; AM Boerbooms; P J van't Pad Bosch; P Reekers
Remarkably similar response to gold therapy in HLA identical sibs with rheumatoid arthritis.
Annals of the rheumatic diseases 1986;45(12):1004-6.
1986: F A Van den Ouweland; F W Gribnau; Y Tan; C A Van Ginneken; L B A Van De Putte
Hypoalbuminaemia and naproxen pharmacokinetics in a patient with rheumatoid arthritis.
Clinical pharmacokinetics 1986;11(6):511-5.
1986: M J Franssen; C L van Herwaarden; L B A Van De Putte; F W Gribnau
Lung function in patients with ankylosing spondylitis. A study of the influence of disease activity and treatment with nonsteroidal antiinflammatory drugs.
The Journal of rheumatology 1986;13(5):936-40.
1986: F Speerstra; P L van Riel; P Reekers; L B A Van De Putte; J P Vandenbroucke
The influence of HLA phenotypes on the response to parenteral gold in rheumatoid arthritis.
Tissue antigens 1986;28(1):1-7.
1986: M J Franssen; F W Gribnau; L B A Van De Putte
A comparison of diflunisal and phenylbutazone in the treatment of ankylosing spondylitis.
Clinical rheumatology 1986;5(2):210-20.
1986: M J Franssen; Y Tan; L B A Van De Putte; C A van Ginneken; F W Gribnau
Pharmacokinetics of naproxen at two dosage regimens in healthy volunteers.
International journal of clinical pharmacology, therapy, and toxicology 1986;24(3):139-42.
1985: M J Franssen; L B A Van De Putte; F W Gribnau
IgA serum levels and disease activity in ankylosing spondylitis: a prospective study.
Annals of the rheumatic diseases 1985;44(11):766-71.
1985: F Speerstra; P Reekers; L B A Van De Putte; J P Vandenbroucke
HLA associations in aurothioglucose- and D-penicillamine-induced haematotoxic reactions in rheumatoid arthritis.
Tissue antigens 1985;26(1):35-40.
1985: W J Habets; D J de Rooij; M H Hoet; L B A Van De Putte; Walther J van Venrooij
Quantitation of anti-RNP and anti-Sm antibodies in MCTD and SLE patients by immunoblotting.
Clinical and experimental immunology 1985;59(2):457-66.
1984: F Speerstra; L B A Van De Putte; J J Rasker; P Reekers; J P Vandenbroucke
The relationship between aurothioglucose- and D-penicillamine-induced proteinuria.
Scandinavian journal of rheumatology 1984;13(4):363-8.
1983: F Speerstra; P Reekers; L B A Van De Putte; J P Vandenbroucke; J J Rasker; D J de Rooij
HLA-DR antigens and proteinuria induced by aurothioglucose and D-penicillamine in patients with rheumatoid arthritis.
The Journal of rheumatology 1983;10(6):948-53.
1982: W B van den Berg; H J van Beusekom; L B A Van De Putte; W A Zwarts; M van der Sluis
Antigen handling in antigen-induced arthritis in mice: an autoradiographic and immunofluorescence study using whole joint sections.
The American journal of pathology 1982;108(1):9-16.
1982: F Speerstra; AM Boerbooms; L B A Van De Putte; H J Kruls; U J van Haelst; G P Vooijs
Arthritis caused by metastatic melanoma.
Arthritis and rheumatism 1982;25(2):223-6.
1982: F Speerstra; AM Boerbooms; L B A Van De Putte; H J van Beusekom; M W Kruijsen; J P Vandenbroucke
Side-effects of azathioprine treatment in rheumatoid arthritis: analysis of 10 years of experience.
Annals of the rheumatic diseases 1982;41 Suppl 1():37-9.
1981: W B van den Berg; M W Kruijsen; L B A Van De Putte; H J van Beusekom; M van der Sluis-van der Pol; W A Zwarts
Antigen-induced and zymosan-induced arthritis in mice: studies on in vivo cartilage proteoglycan synthesis and chondrocyte death.
British journal of experimental pathology 1981;62(3):308-16.
1980: L B A Van De Putte; J H Berden; M T Boerbooms; W H Muller; Johannes J Rasker; A Reynvaan-Groendijk; S M van der Linden
Reactive arthritis after Campylobacter jejuni enteritis.
The Journal of rheumatology 1980;7(4):531-5.
1980: G E Storms; M W Kruijsen; H J Van Beusekom; L B A Van De Putte; A M Boerbooms; W H Penn; T J Van Rens
Pathological fracture of the odontoid process in rheumatoid arthritis.
The Netherlands journal of medicine 1980;23(2):120-22.